Drug intelligence / Profile preview

hylan

Development stage
Unknown
Lead developer
Sanofi
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic, Intraarticular
01

Overview

Hylan is a chemically modified, cross-linked derivative of hyaluronan (hyaluronic acid) designed to enhance the viscoelastic properties and molecular weight of the native polysaccharide. By cross-linking the hyaluronan chains, hylan achieves greater viscosity and stability while maintaining the biocompatibility and non-immunogenicity of the original molecule. In the context of ophthalmology and orbital surgery, specifically researched by **Amsterdam UMC**, hylan A is utilized as a viscoadaptive lubricant in eye drop formulations. Its primary mechanism involves providing a long-lasting, protective moisture film that reduces mechanical friction between an ocular prosthesis and the conjunctival socket. This reduction in friction is critical for treating ocular prosthesis-related discomfort and chronic mucopurulent discharge in anophthalmic patients, where traditional lubricants often fail due to rapid drainage or insufficient cushioning.

Brand names
SynviscHylocomodHylan G-F 20
Other names
hylan Ahylan Bcross-linked hyaluronanhylan polymers
02

Targets

RHAMM (Hyaluronan-mediated motility receptor)CD44 (CD44 antigen)

Beyond the preview

Go deeper on hylan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hylan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call